CClinicalTrials.gg
CompletedNCT00605202Updated Dec 15, 2009Results posted

Effect of Licorice and Hydrochlorothiazide on Plasma Potassium

A Phase 4 interventional study of Hydrochlorothiazide and Licorice in Hypokalemia, sponsored by University of Oulu. Completed at 1 site in Finland. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2009-12-15.

Sponsored by University of Oulu · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
10
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

This clinical trial is designed to study the effect of the combination of licorice and hydrochlorothiazide on plasma potassium levels in volunteers. In one arm, 10 healthy volunteers will be given 32 grams of licorice a day together with a 25 mg dose of daily hydrochlorothiazide for 14 days. This combination is compared with 32 grams of licorice a day for 14 days given in the other arm. The study is a randomized, open-label cross-over trial. There is at least a 3-week wash-out between the arms. The hypothesis is that the combination of licorice and hydrochlorothiazide will cause hypokalemia. The main outcome measure is the change in the plasma level of potassium between the arms.

02

Conditions studied

  • Hypokalemia

Browse trials for

03

In context

Hypokalemia

26 studies on the registry are indexed under Hypokalemia; 5 are open to participants now.

This study's enrollment of 10 is below the median of 73 across 18 interventional studies indexed under Hypokalemia.

Browse Hypokalemia studies →

Lead sponsor

University of Oulu is the lead sponsor of 138 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Healthy volunteer
  • Age 18-40 years

Exclusion criteria

Exclusion Criteria:

  • Any continuous medication
  • Any significant disease
  • Hypotension or hypertension
  • Allergy to licorice or hydrochlorothiazide
  • Pregnancy and breast feeding
  • Fear of needles and previous difficult blood samplings
  • Substance abuse
  • Participation in another clinical drug trial within 1 month of enrollment
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
10 participants (actual)

Study arms

  • Active comparator
    Licorice

    Dietary Supplement: Licorice

  • Active comparator
    Licorice and HCTZ

    Drug: Hydrochlorothiazide

Interventions

  • DrugHydrochlorothiazide

    Hydrochlorothiazide 25 mg a day for 14 days.

    Also known as: Hydrex semi, ATC C03AA03

  • Dietary supplementLicorice

    Licorice candy 32 grams a day for 14 days.

    Also known as: Pepe Original candy

06

What researchers measure

Primary outcomes

  1. Plasma Potassium

    Plasma potassium measured with indirect ion specific electrode method

    Time frame: Baseline and 2 weeks

07

Results

Posted Dec 9, 2009

Participant flow

First Intervention
Participant flow — First Intervention
MilestoneLicorice First, Then Licorice and HCTZLicorice and HCTZ First, Then Licorice
Started55
Completed55
Not completed00
Washout Period of 3 Weeks
Participant flow — Washout Period of 3 Weeks
MilestoneLicorice First, Then Licorice and HCTZLicorice and HCTZ First, Then Licorice
Started55
Completed55
Not completed00
Second Intervention
Participant flow — Second Intervention
MilestoneLicorice First, Then Licorice and HCTZLicorice and HCTZ First, Then Licorice
Started55
Completed55
Not completed00

Outcome measures

PrimaryPlasma Potassium

Plasma potassium measured with indirect ion specific electrode method

Time frame:
Baseline and 2 weeks
Reported as:
Mean · mmol/l
Plasma Potassium
mmol/lLicoriceLicorice and HCTZ
Baseline4.0 ± 0.24.0 ± 0.3
2 weeks4.1 ± 0.33.7 ± 0.2
Statistical analysis
  • Licorice vs Licorice and HCTZ · t-test, 2 sided · p = 0.007 (P-value of the change in the plasma potassium (baseline to 2 weeks) between arms)

Adverse events

Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Licorice—0/10 (0%)0/10 (0%)
Licorice and HCTZ—0/10 (0%)0/10 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Entire Study Population
<=18 years0
Between 18 and 65 years10
>=65 years0
Sex: Female, Male
Sex: Female, Male(Participants)Entire Study Population
Female5
Male5
Region of Enrollment
Region of Enrollment(participants)Entire Study Population
Finland10
08

Study locations

1 site
  • Oulu University Hospital
    Oulu, 90220, Finland
09

References and documents

Publications

  • Hukkanen J, Ukkola O, Savolainen MJ. Effects of low-dose liquorice alone or in combination with hydrochlorothiazide on the plasma potassium in healthy volunteers. Blood Press. 2009;18(4):192-5. doi: 10.1080/08037050903072515. PubMed 19562574 ↗
10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 15, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00605202
Lead sponsor
University of Oulu
First posted
Jan 30, 2008
Start date
Feb 2008
Primary completion
Jan 2009
Completion
Jan 2009
Results posted
Dec 9, 2009
Last update
Dec 15, 2009

Study contacts

Markku Savolainen, MD
principal investigator · Oulu University Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion